Friday, April 30, 2021

US FDA News: FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose

FDA approves a higher dose naloxone nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity.
Read more: FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose